The surgical management of glaucoma: A review
R Lim - Clinical & Experimental Ophthalmology, 2022 - Wiley Online Library
After a long period of little change, glaucoma surgery has experienced a dramatic rise in the
number of possible procedures in the last two decades. Glaucoma filtering surgeries with …
number of possible procedures in the last two decades. Glaucoma filtering surgeries with …
XEN® Gel Stent: A Comprehensive Review on Its Use as a Treatment Option for Refractory Glaucoma
AM Fea, GM Durr, P Marolo, L Malinverni… - Clinical …, 2020 - Taylor & Francis
Abstract The XEN Gel Microstent is a subconjunctival microinvasive glaucoma surgical
device developed with the aim of improving the predictability and safety profile of bleb …
device developed with the aim of improving the predictability and safety profile of bleb …
Primary open-angle glaucoma preferred practice pattern®
SJ Gedde, K Vinod, MM Wright, KW Muir, JT Lind… - Ophthalmology, 2021 - Elsevier
Background Primary open angle glaucoma (POAG) is a chronic, progressive ocular disease
causing loss of the optic nerve rim and retinal nerve fiber layer (RNFL) with associated …
causing loss of the optic nerve rim and retinal nerve fiber layer (RNFL) with associated …
Two-year results of a multicenter study of the ab interno gelatin implant in medically uncontrolled primary open-angle glaucoma
H Reitsamer, C Sng, V Vera, M Lenzhofer… - Graefe's Archive for …, 2019 - Springer
Purpose To evaluate the effectiveness of an ab interno subconjunctival gelatin implant as
primary surgical intervention in reducing intraocular pressure (IOP) and IOP-lowering …
primary surgical intervention in reducing intraocular pressure (IOP) and IOP-lowering …
[HTML][HTML] Safety and effectiveness of the PRESERFLO® MicroShunt in primary open-angle glaucoma: results from a 2-year multicenter study
HJM Beckers, F Aptel, CAB Webers, E Bluwol… - Ophthalmology …, 2022 - Elsevier
Purpose To assess the safety and effectiveness of the PRESERFLO® MicroShunt (formerly
InnFocus MicroShunt) in patients with primary open-angle glaucoma (POAG). Design The …
InnFocus MicroShunt) in patients with primary open-angle glaucoma (POAG). Design The …
Prospective evaluation of standalone XEN gel implant and combined phacoemulsification-XEN gel implant surgery: 1-year results
Purpose: To evaluate the safety and efficacy of XEN gel implant (Allergan Inc., Irvine) as a
standalone versus combined XEN-Phacoemulsification surgery (XEN+ cataract) in …
standalone versus combined XEN-Phacoemulsification surgery (XEN+ cataract) in …
[HTML][HTML] Gel stent versus trabeculectomy: the randomized, multicenter, gold-standard pathway study (GPS) of effectiveness and safety at 12 months
PURPOSE To compare effectiveness and safety of the gel stent to trabeculectomy in open-
angle glaucoma (OAG). DESIGN Prospective, randomized, multicenter, noninferiority study …
angle glaucoma (OAG). DESIGN Prospective, randomized, multicenter, noninferiority study …
Platelet-rich plasma-loaded bioactive chitosan@ sodium alginate@ gelatin shell-core fibrous hydrogels with enhanced sustained release of growth factors for diabetic …
Q Huang, T Wu, Y Guo, L Wang, X Yu, B Zhu… - International Journal of …, 2023 - Elsevier
The ability of autologous platelet-rich plasma (PRP) gel to promote rapid wound healing
without immunological rejection has opened new avenues for the treatment of diabetic foot …
without immunological rejection has opened new avenues for the treatment of diabetic foot …
Comparing the efficacy of trabeculectomy and XEN gel microstent implantation for the treatment of primary open-angle glaucoma: a retrospective monocentric …
T Theilig, M Rehak, C Busch, C Bormann… - Scientific reports, 2020 - nature.com
The aim of this study was to compare the efficacy and safety profile of XEN microstent
implantation with trabeculectomy (TET) in a comparable group of open-angle glaucoma …
implantation with trabeculectomy (TET) in a comparable group of open-angle glaucoma …
Conventional glaucoma implants and the new MIGS devices: a comprehensive review of current options and future directions
Glaucoma is a progressive optic neuropathy that is the second leading cause of preventable
blindness worldwide, after cataract formation. A rise in the intraocular pressure (IOP) is …
blindness worldwide, after cataract formation. A rise in the intraocular pressure (IOP) is …